Zimmer Biomet Holdings (ZBH) Research & Development (2009 - 2026)

Zimmer Biomet Holdings has reported Research & Development for 18 years, with the latest figure at $104.8 million in Q2 2026.

• On a quarterly basis, Research & Development fell 7.5% year-over-year to $104.8 million in Q2 2026; TTM through Jun 2026 was $442.8 million, a 0.27% change from a year earlier, with the FY2025 full-year figure at $458.5 million, up 4.82% from the prior year.
• Research & Development was $104.8 million for Q2 2026 at Zimmer Biomet Holdings, up from $103.4 million in the prior quarter.
• The five-year high for Research & Development was $118.7 million in Q4 2025, with the low at $96.9 million in Q1 2022.
• Average Research & Development over 5 years is $109.4 million, with a median of $109.9 million recorded in 2023.
• The largest YoY upside for Research & Development was 19.63% in 2022 against a maximum downside of 39.76% in 2022.
• Over 5 years, Research & Development stood at $108.0 million in 2022, then advanced by 4.91% to $113.3 million in 2023, then dropped by 4.24% to $108.5 million in 2024, then rose by 9.4% to $118.7 million in 2025, then fell by 11.71% to $104.8 million in 2026.
• The last three Research & Development figures came in at $104.8 million (Q2 2026), $103.4 million (Q1 2026), and $118.7 million (Q4 2025), per Business Quant data.